Abstract | PURPOSE: METHODS AND MATERIALS: Effects of irradiation and/or ZD6474, a small-molecule inhibitor of VEGFR2 and EGFR tyrosine kinases, were studied in vitro for human lung adenocarcinoma cells by using proliferation and clonogenic assays. The feasibility of combining ZD6474 with radiation therapy was then evaluated in an orthotopic model of human lung adenocarcinoma. Lung tumor burden and spread within the thorax were assessed, and tumor and adjacent tissues were analyzed by means of immunohistochemical staining for multiple parameters, including CD31, VEGF, VEGFR2, EGF, EGFR, matrix metalloproteinase-2 and -9, and basic fibroblast growth factor. RESULTS: CONCLUSIONS: When radiation therapy is combined with VEGFR2 and EGFR blockade, significant enhancement of antiangiogenic, antivascular, and antitumor effects are seen in an orthotopic model of lung cancer. These data provide support for clinical trials of biologically targeted and conventional therapies for human lung cancer.
|
Authors | Keiko Shibuya, Ritsuko Komaki, Tomoaki Shintani, Satoshi Itasaka, Anderson Ryan, Juliane M Jürgensmeier, Luka Milas, Kian Ang, Roy S Herbst, Michael S O'Reilly |
Journal | International journal of radiation oncology, biology, physics
(Int J Radiat Oncol Biol Phys)
Vol. 69
Issue 5
Pg. 1534-43
(Dec 01 2007)
ISSN: 0360-3016 [Print] United States |
PMID | 17889445
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Piperidines
- Quinazolines
- Radiation-Sensitizing Agents
- Vascular Endothelial Growth Factor A
- Epidermal Growth Factor
- ErbB Receptors
- Receptors, Vascular Endothelial Growth Factor
- Vascular Endothelial Growth Factor Receptor-2
- vandetanib
|
Topics |
- Animals
- Cell Line, Tumor
- Cell Proliferation
- Combined Modality Therapy
(methods)
- DNA Repair
(drug effects)
- Epidermal Growth Factor
(metabolism)
- ErbB Receptors
(antagonists & inhibitors)
- Feasibility Studies
- Humans
- Lung Neoplasms
(blood supply, metabolism, radiotherapy)
- Male
- Mice
- Mice, Nude
- Neovascularization, Pathologic
(prevention & control)
- Piperidines
(therapeutic use)
- Pleural Effusion
(prevention & control)
- Quinazolines
(therapeutic use)
- Radiation Tolerance
(drug effects)
- Radiation-Sensitizing Agents
(therapeutic use)
- Receptors, Vascular Endothelial Growth Factor
(antagonists & inhibitors)
- Vascular Endothelial Growth Factor A
(metabolism)
- Vascular Endothelial Growth Factor Receptor-2
(antagonists & inhibitors)
- Xenograft Model Antitumor Assays
|